SIREN : 837962349
NOMADE PHARMA is a French company founded 8 years ago, specialized in the sector Services administratifs combinés de bureau. Based in EVREUX (27000), this company of category PME shows in 2020 a net income positive of 38 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Data updated on 2026-05-02
Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy
| Indicator | 2020 |
|---|---|
| Revenue | N/C |
| Net income | 37 707 € |
| EBITDA | N/C |
| Net margin | N/C |
In 2020, NOMADE PHARMA generates positive net income of 38 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
37 707 €
The debt ratio (= Financial debt / Equity x 100) stands at 416%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 19%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
415.677%
19.375%
In 2020, the debt ratio of NOMADE PHARMA (415.68) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
In 2020, the financial autonomy of NOMADE PHARMA (19.4%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
The liquidity ratio (= Current assets / Current liabilities) stands at 3745.26. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
3745.261
In 2020, the liquidity ratio of NOMADE PHARMA (3745.26) ranks in the top 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio above 1 ensures comfortable coverage of short-term maturities.
Based on 173 transactions of similar company sales (all years), the value of NOMADE PHARMA is estimated at 132 888 € (range 46 606€ - 359 413€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Only this financial indicator is available for this company.
This estimate is based on the analysis of 173 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Compare NOMADE PHARMA with other companies in the same sector:
Voir toutes les statistiques du secteur Services administratifs combinés de bureau
The revenue of NOMADE PHARMA is not publicly disclosed (confidential accounts filed with INPI).
Yes, NOMADE PHARMA generated a net profit of 38 k€ in 2020.
The headquarters of NOMADE PHARMA is located in EVREUX (27000), in the department Eure.
The tax return of NOMADE PHARMA is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
NOMADE PHARMA operates in the sector Services administratifs combinés de bureau (NAF code 82.11Z). See the 'Sector positioning' section above to compare the company with its competitors.